RUNX1 and endometrial cancer: MMP-9 and MMP-2 were increased in invasive endometrial cancer, and the high amounts of MMP-9 and MMP-2 colocalized with ETV5/ERM and RUNX1/AML1 (factors associated with neoplastic progression) (Planagumà et al., 2011).